**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 5216-25-1 |4-Chlorobenzotrichloride | 99% | 226-009-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: C
Risk Phrases: 22 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Causes burns.Moisture sensitive.Lachrymator
(substance which increases the flow of tears).Corrosive.
Potential Health Effects
Eye:
Causes eye burns. Produces irritation, characterized by a burning
sensation, redness, tearing, inflammation, and possible corneal
injury. Lachrymator (substance which increases the flow of tears).
May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold
and clammy skin with cyanosis or pale color.
Ingestion:
Causes gastrointestinal tract burns. May cause perforation of the
digestive tract. May cause cardiac disturbances. May cause central
nervous system effects. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. Aspiration may lead
to pulmonary edema. May cause cardiac abnormalities. May cause
systemic effects.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid immediately. Do NOT allow victim to rub eyes or keep
eyes closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Vapors may
be heavier than air. They can spread along the ground and collect
in low or confined areas. Contact with metals may evolve flammable
hydrogen gas. Containers may explode when heated. Contact with water
forms corrosive vapors. Runoff from fire control or dilution water
may cause pollution.
Extinguishing Media:
Do NOT get water inside containers. For small fires, use dry
chemical, carbon dioxide, or water spray. For large fires, use dry
chemical, carbon dioxide, alcohol-resistant foam, or water spray.
Cool containers with flooding quantities of water until well after
fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation. Do not get water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Use only in a well-ventilated area. Do not breathe dust, vapor,
mist, or gas. Do not get in eyes, on skin, or on clothing. Keep
container tightly closed. Do not ingest or inhale. Do not allow
contact with water. Discard contaminated shoes. Keep from contact
with moist air and steam.
Storage:
Keep container closed when not in use. Corrosives area. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 5216-25-1:
Russia: 0.01 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear green
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.04 hPa @ 20 C
Viscosity: Not available.
Boiling Point: 245 deg C @ 760.00mm Hg
Freezing/Melting Point: 5.8 deg C
Autoignition Temperature: 505 deg C ( 941.00 deg F)
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >300 deg C
Solubility in water: decomposes
Specific Gravity/Density: 1.4950g/cm3
Molecular Formula: C7H4Cl4
Molecular Weight: 229.92
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, moisture, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents, moisture.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 5216-25-1: XT8580000
LD50/LC50:
CAS# 5216-25-1: Inhalation, mouse: LC50 = 125 mg/m3; Inhalation,
rat: LC50 = 125 mg/m3; Oral, mouse: LD50 = 700 mg/kg; Oral, rat: LD50
= 820 mg/kg; Skin, rabbit: LD50 = >2 gm/kg.
Carcinogenicity:
4-Chlorobenzotrichloride -
California: carcinogen, initial date 1/1/90
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CORROSIVE LIQUID, N.O.S.*
Hazard Class: 8
UN Number: 1760
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 22 Harmful if swallowed.
R 34 Causes burns.
Safety Phrases:
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 5216-25-1: 3
Canada
CAS# 5216-25-1 is listed on Canada's NDSL List.
CAS# 5216-25-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5216-25-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #7 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,6-Pyridinedicarboxylic Acid Chloride, 97%
| 3739-94-4 |
|
OPD tablets, 120 mg/tablet
| 615-28-1 |
|
Tetrabutylphosphonium bromide, 98%
| 3115-68-2 |
|
2'-Deoxyguanosine 5'-Monophosphate, Sodium Salt Hydrate
| 52558-16-4 |
|
4-(Dimethylamino)pyridinium Bromide Perbromide
| 92976-81-3 |
|
Mercury(ii) thiocyanate, p.a.
| 592-85-8 |
|
Beta-Ionone, Synthetic, 96%
| 14901-07-6 |
|
Quercetin (Pract)
| 117-39-5 |
|
4-Chlorobenzotrichloride, 99%
| 5216-25-1 |
|
1-Iodopropane, 99%, Stabilized over Copper
| 107-08-4 |
|
2-Acetyl-1-methylpyrrole, 99%
| 932-16-1 |
|
4-Dimethylamino-4'-nitrostilbene
| 4584-57-0 |
|
Pentafluorothiophenol, 97%
| 771-62-0 |
|
1-(4-METHOXYPHENYL)-1-CYCLOPROPANE- CARBONITRILE
| 16728-00-0 |
|
Triphenylthioantimonate, 99%
| 28609-58-7 |
|
4-Methylthiazole, 99%
| 693-95-8 |
|
DL-2-Amino-1-Propanol, 98%
| 6168-72-5 |
|
2,5-Diphenyl-p-benzoquinone (pract), 93% (uv-vis)
| 844-51-9 |
|
4-Methylbenzyltriphenylphosphonium chloride, 99%
| 1530-37-6 |
|
L-(+)-Prolinol
| 23356-96-9 |
|
Prostaglandin VIII, 99%
| 0-01-1 |
|
Allyl alcohol
| 107-18-6 |
|
Phosphorus Tribromide, 99%
| 7789-60-8 |
|
5-Nitroisoquinoline, 98%
| 607-32-9 |
|
1,3-Acetonedicarboxylic acid, 96%
| 542-05-2 |
|
Pentacene, 98%
| 135-48-8 |
|
3,3'-Dimethoxybenzidine dihydrochloride, 99% (titr.)
| 20325-40-0 |
|
Diethyl Bis(hydroxymethyl)malonate, 95% (HPLC)
| 20605-01-0 |
|
P-Bromo-DL-Phenylalanine, 99%
| 14091-15-7 |
|
1,2-(Didodecyloxy)benzene, 98% (GC)
| 42244-53-1 |
|
p-Anisaldehyde, 99+%
| 123-11-5 |
|
Diazogen, 99%
| 80-11-5 |
|
2-Fluoro-4-Nitrotoluene, 98%
| 1427-07-2 |
|
Sodium triacetoxyborohydride
| 56553-60-7 |
|
Indole-2-carboxylic acid, 99%
| 1477-50-5 |
|
Pyridoxine Hydrochloride, 99% (Titr.)
| 58-56-0 |
|
2,6-Dichlorophenol
| 87-65-0 |
|
1,2-Butanediol, 98%
| 26171-83-5 |
|
2-(2-Aminoethoxy)ethanol, 98%
| 929-06-6 |
|
Poly(propylene Glycol), Average M.W. 425
| 25322-69-4 |
|
Valinomycin, 96% (HPLC)
| 2001-95-8 |
|
7-Amino-4-Methyl-1,8-Naphthyridin-2-ol, 98 %
| 1569-15-9 |
|
Benzyl butyrate, 98%
| 103-37-7 |
|
Lutetium oxide, 99.99%, -325 mesh
| 12032-20-1 |
|
P-Nitrophenyl Chloroformate, 96% (Titr.)
| 7693-46-1 |
|
Potassium sorbate, 99%
| 590-00-1 |
|
Phthalan, 97%
| 496-14-0 |
|
Cinnamyl Acetate, 99+%
| 103-54-8 |
|
Butyl Isocyanatoacetate, 98% (GC)
| 17046-22-9 |
|
Zirconyl(IV) chloride octahydrate, 98+%
| 7699-43-6 |
|
|